BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 8804361)

  • 1. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
    Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
    Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
    Shih IM; Nesbit M; Herlyn M; Kurman RJ
    Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD146 (Mel-CAM) in biology and pathology.
    Shih IM
    J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies.
    Shih IM; Kurman RJ
    Hum Pathol; 1998 Jan; 29(1):27-33. PubMed ID: 9445130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental site nodule and characterization of distinctive types of intermediate trophoblast.
    Shih IM; Seidman JD; Kurman RJ
    Hum Pathol; 1999 Jun; 30(6):687-94. PubMed ID: 10374778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
    Shih IM; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
    Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
    Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
    Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
    Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
    Bamberger AM; Sudahl S; Wagener C; Löning T
    Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.
    Bozić M; Petronijević M; Milenković S; Atanacković J; Lazić J; Vićovac Lj
    Placenta; 2004 Nov; 25(10):797-802. PubMed ID: 15451194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
    Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
    J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.
    Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M
    Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms.
    Shih IM; Wang TL; Westra WH
    Clin Cancer Res; 1996 Mar; 2(3):569-75. PubMed ID: 9816205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.